טוען...
Re-formulating Gehan’s design as a flexible two-stage single-arm trial
BACKGROUND: Gehan’s two-stage design was historically the design of choice for phase II oncology trials. One of the reasons it is less frequently used today is that it does not allow for a formal test of treatment efficacy, and therefore does not control conventional type-I and type-II error-rates....
שמור ב:
| הוצא לאור ב: | BMC Med Res Methodol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6350340/ https://ncbi.nlm.nih.gov/pubmed/30691398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-019-0659-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|